Dr. Wissam Khattar Mechleb, MD

Dr. Mechleb practices at Forrest General Hospital in Hattiesburg, Mississippi, part of Forrest County, MS.

Dr. Mechleb's NPI, 1487841847, was assigned on October 1, 2007. Dr. Mechleb holds Mississippi license 21893.

Dr. Mechleb's primary practice is Forrest General Hospital, at 6051 US Highway 49, Hattiesburg, MS 39401 in Forrest County. The practice phone is (601) 288-7000.

Dr. Mechleb's primary practice is Forrest General Hospital in Hattiesburg, Mississippi, part of Forrest County, MS. Dr. Mechleb is also affiliated with East Jefferson General Hospital. The medical group on file is Hattiesburg Clinic. Dmand AI also links Dr. Mechleb to 3 more hospitals, 4 medical groups, 2 group practices and clinics and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mechleb practices, 8 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Mechleb's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Mechleb is licensed in Mississippi.

CMS data shows 5,800 Medicare services from Dr. Mechleb across 34 procedure codes in 2024, for 1,676 Medicare patients. Medicare paid $611,986 for them.

CMS counts 1,676 Medicare patients who saw Dr. Mechleb in 2024. The largest group is 65 to 74, with 659 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mechleb's median patient age at 71, with 57% women.

In 2024, Dr. Mechleb wrote 5,828 Medicare Part D claims for 721 patients. 79% of them were for generic drugs. CMS names the drug for 5,662 of them, across 42 drugs with 11 or more claims each, at $954,842 in total drug cost. In 2023, CMS named 4,862 claims across 37 drugs.

Dr. Mechleb accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Mechleb. Dr. Mechleb's most frequent co-authors are Lucien Naji Abboud, MD, Tariq Ziad Haddadin, MD and Costy S. Mattar.

CMS Open Payments shows 81 general payments to Dr. Mechleb from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Janssen Pharmaceuticals, Inc paid the most, $401.